These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 20925474

  • 21. Dopamine vs noradrenaline: inverted-U effects and ADHD theories.
    Levy F.
    Aust N Z J Psychiatry; 2009 Feb; 43(2):101-8. PubMed ID: 19153917
    [Abstract] [Full Text] [Related]

  • 22. The alpha(2C)-adrenergic receptor mediates hyperactivity of coloboma mice, a model of attention deficit hyperactivity disorder.
    Bruno KJ, Hess EJ.
    Neurobiol Dis; 2006 Sep; 23(3):679-88. PubMed ID: 16839770
    [Abstract] [Full Text] [Related]

  • 23. The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex.
    Arnsten AF.
    J Pediatr; 2009 May 01; 154(5):I-S43. PubMed ID: 20596295
    [Abstract] [Full Text] [Related]

  • 24. Catecholamine regulation of the prefrontal cortex.
    Arnsten AF.
    J Psychopharmacol; 1997 May 01; 11(2):151-62. PubMed ID: 9208378
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders.
    Arnsten AF, Rubia K.
    J Am Acad Child Adolesc Psychiatry; 2012 Apr 01; 51(4):356-67. PubMed ID: 22449642
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Alpha-2 agonists in the treatment of attention deficit hyperactivity disorder.
    Scahill L, Barloon L, Farkas L.
    J Child Adolesc Psychiatr Nurs; 1999 Apr 01; 12(4):168-73. PubMed ID: 10876518
    [No Abstract] [Full Text] [Related]

  • 37. Prefrontal cortex Homer expression in an animal model of attention-deficit/hyperactivity disorder.
    Hong Q, Zhang M, Pan XQ, Guo M, Li F, Tong ML, Chen RH, Guo XR, Chi X.
    J Neurol Sci; 2009 Dec 15; 287(1-2):205-11. PubMed ID: 19709672
    [Abstract] [Full Text] [Related]

  • 38. Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats.
    Dela Peña I, Shen G, Shi WX.
    Eur J Pharmacol; 2021 Feb 05; 892():173826. PubMed ID: 33347825
    [Abstract] [Full Text] [Related]

  • 39. Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents.
    Rizzo R, Martino D.
    Expert Rev Neurother; 2015 Apr 05; 15(4):347-54. PubMed ID: 25800130
    [Abstract] [Full Text] [Related]

  • 40. [α2-Adrenergic agonists, and drugs for ADHD].
    Clement HW, Schulz E.
    Pharm Unserer Zeit; 2011 Nov 05; 40(6):503-9. PubMed ID: 22028136
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.